According to NewAmsterdam Pharma Company's latest financial reports the company has $0.42 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.34 B | -32.14% |
2022-12-31 | $0.50 B | 636.99% |
2021-12-31 | $68.07 M | 472.44% |
2020-12-31 | $11.89 M |